The best substitute for spironolactone depends entirely on why you’re taking it, because spironolactone wears many hats. It is prescribed for heart failure, resistant high blood pressure, hormonal acne, female-pattern hair loss, hirsutism, fluid retention from liver disease, and as part of gender-affirming hormone therapy. A swap that works perfectly for one condition may be useless or even harmful for another. The good news is that alternatives exist for virtually every use case, and some of them carry fewer side effects.
Why People Look for Alternatives
Spironolactone blocks aldosterone receptors, which helps the body shed excess fluid and sodium while holding onto potassium. But because it is not very selective, it also interferes with androgen and progesterone receptors. That lack of selectivity is a double-edged sword. It makes spironolactone useful for androgen-driven conditions like acne and unwanted hair growth, but it also causes side effects that push people to look for something else. Breast tenderness and breast tissue growth (gynecomastia) in men, irregular periods and breast pain in women, elevated potassium, dizziness, and fatigue are the most common complaints. In men with heart failure, the gynecomastia alone is enough to make some patients stop treatment. For anyone already prone to high potassium levels, the risk of dangerous hyperkalemia is a serious concern, especially when spironolactone is combined with other drugs that raise potassium.
Alternatives for Heart Failure and Blood Pressure
If you’re taking spironolactone for heart failure or resistant hypertension, eplerenone is the most direct substitute. Like spironolactone, eplerenone blocks aldosterone receptors, but it is far more selective. It largely avoids the androgen and progesterone receptors, which means side effects like gynecomastia and vaginal bleeding are considerably less likely.1PubMed. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone In patients with liver cirrhosis who developed painful breast enlargement on spironolactone, switching to eplerenone reversed the pain and was well tolerated.2PubMed Central. Eplerenone reverses spironolactone-induced painful gynaecomastia in cirrhotics The trade-off is potency: eplerenone binds the mineralocorticoid receptor much less tightly than spironolactone, so you generally need a higher dose to get an equivalent effect.3PubMed Central. The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction It also tends to cost more, and some insurance plans resist covering it when spironolactone is available.
Finerenone is a newer, non-steroidal mineralocorticoid receptor antagonist that has gotten a lot of attention for kidney and heart protection in people with type 2 diabetes. Because it is non-steroidal, it avoids the hormonal side effects of spironolactone altogether. Its approved use is currently focused on chronic kidney disease with diabetes, so it is not a drop-in replacement for spironolactone in general heart failure, but the research is expanding rapidly.
For people whose main goal is just to spare potassium while taking a loop or thiazide diuretic, amiloride and triamterene are older alternatives. They reduce potassium loss through a completely different mechanism and do not touch hormone receptors at all, so they sidestep the endocrine side effects. However, they also lack the specific survival benefits that aldosterone blockers have shown in heart failure trials, so they are not true substitutes when spironolactone is being used for its proven mortality benefit.4Drug and Therapeutics Bulletin. Potassium-sparing diuretics: spironolactone v. triamterene and amiloride
SGLT2 inhibitors (drugs like dapagliflozin and empagliflozin, originally developed for diabetes) have emerged as a compelling option in heart failure. A large nationwide cohort study found that when SGLT2 inhibitors were started instead of mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction, they were associated with roughly a 30% lower risk of death and a 35% lower risk of cardiovascular death.5The Lancet Regional Health – Europe. Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study They carry a much lower risk of hyperkalemia, which makes them attractive for people with kidney disease or those already on drugs that raise potassium. In practice, many heart failure specialists now use SGLT2 inhibitors and mineralocorticoid receptor antagonists together rather than choosing one over the other, but for patients who cannot tolerate spironolactone, an SGLT2 inhibitor offers a strong alternative path.
Alternatives for Acne
Spironolactone is widely prescribed off-label for hormonal acne in women, where it works by blocking the androgen receptors in skin that drive oil production and breakouts. If you need to switch, the options break into topical and systemic categories.
Clascoterone is the first topical anti-androgen approved for acne. It competes with dihydrotestosterone for androgen receptor binding directly in the skin, which means it acts locally without entering the bloodstream in meaningful amounts. Long-term safety studies showed no systemic anti-androgenic effects like reduced libido or feminization, even in male participants.6PubMed. Clascoterone: a new topical anti-androgen for acne management That makes it an appealing option for men with hormonal acne (who cannot take spironolactone at all) and for women who want to avoid the systemic side effects. The limitation is that a cream applied to the face may not address acne driven by body-wide hormonal imbalance the way an oral medication can.
Oral contraceptives containing drospirenone are another common switch. Drospirenone is a synthetic progestin with mild anti-androgen and anti-mineralocorticoid activity, so it acts on some of the same pathways as spironolactone. A randomized trial found that drospirenone combined with ethinyl estradiol was as effective as cyproterone acetate (a stronger anti-androgen) for treating moderate-to-severe acne with hyperandrogenism, along with hirsutism and menstrual irregularities.7Indonesian Journal of Obstetrics and Gynecology. Drospirenone–Ethinyl Estradiol and Cyproterone Acetate in Moderate Severe Acne with Hyperandrogenism: A Randomized Double-Blind Trial These are only an option for people who can and want to take combined oral contraceptives, which rules out anyone with a history of blood clots, certain migraines, or other contraindications.
Isotretinoin (sometimes still known by its former brand name Accutane) targets acne through a completely different route: it dramatically reduces sebum production and has lasting effects that can persist for years after a course ends. A randomized trial in women with hyperandrogenism found that all participants showed clinical improvement after eight weeks, with a triple-therapy group combining low-dose isotretinoin, spironolactone, and diammonium glycyrrhizinate achieving about a 90% lesion clearance rate, while low-dose isotretinoin alone cleared roughly 74% of lesions.8Dermatologic Therapy. Efficacy and Safety of Low‐Dose Isotretinoin, Spironolactone, and Diammonium Glycyrrhizinate for Acne in Women With Hyperandrogenism: A Randomized Controlled Trial Isotretinoin requires strict pregnancy prevention due to severe birth defect risk, and it comes with drying side effects, so it is generally reserved for more stubborn cases.
Alternatives for Female-Pattern Hair Loss
Spironolactone is used off-label for female-pattern hair loss because it reduces the effects of androgens on hair follicles. The evidence base for alternatives in women specifically is thinner than you might expect, since most large hair-loss trials focus on men.
Finasteride and dutasteride, both 5-alpha reductase inhibitors, block the conversion of testosterone into dihydrotestosterone, the androgen most responsible for miniaturizing hair follicles. A three-year study in 120 women found that about 82% in the finasteride group and 83% in the dutasteride group showed increased hair thickness, with dutasteride performing somewhat better in women under 50 at the crown area of the scalp.9PubMed. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia These drugs are not approved for use in women in many countries and carry pregnancy risks similar to isotretinoin, so reliable contraception is mandatory. A systematic review noted that high-quality research on dutasteride for female hair loss is still limited, though individual case reports have shown striking improvement even after other treatments failed.10PubMed Central. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
Low-dose oral minoxidil is increasingly popular and may be used alongside spironolactone rather than instead of it. A pilot study found that a daily capsule combining 0.25 mg of oral minoxidil with 25 mg of spironolactone appeared safe and effective for female-pattern hair loss.11PubMed. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone For someone who cannot tolerate spironolactone, low-dose oral minoxidil alone is an option many dermatologists now prescribe, though it works by a different mechanism (improving blood flow to follicles) rather than blocking androgens. The most common side effect is unwanted hair growth on the face and body, which some people find manageable and others do not.
Alternatives for Hirsutism
Unwanted facial and body hair growth, often linked to polycystic ovary syndrome (PCOS) or other causes of elevated androgens, is one of the classic reasons spironolactone gets prescribed. Several alternatives exist, each with distinct trade-offs.
Flutamide is a potent androgen receptor blocker that was originally developed for prostate cancer. At the high doses used in oncology, liver toxicity was a genuine concern. However, at the low doses used for hirsutism, the picture is reassuring. A study following 214 women with excess androgens on low-dose flutamide (125 or 250 mg daily) for a full year found zero cases of elevated liver enzymes and no evidence of liver toxicity.12PubMed. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism Liver monitoring is still recommended, but the safety profile at these doses is much better than flutamide’s reputation suggests. Flutamide is not available everywhere, and prescribers in some countries remain uncomfortable with it because of the older high-dose safety data.
Metformin, the diabetes drug, offers an indirect approach for hirsutism tied to PCOS. It does not block androgens directly. Instead, it improves insulin sensitivity, and in PCOS, lower insulin levels lead to lower androgen production by the ovaries. A trial comparing metformin to a standard anti-androgen oral contraceptive (cyproterone acetate with ethinyl estradiol) found that metformin was at least as effective at reducing hirsutism scores and patient-reported outcomes, despite causing negligible changes in measured androgen levels.13PubMed. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome That result suggests the insulin pathway matters more for hair growth than the raw hormone numbers would predict. Metformin is cheap, widely available, and generally well tolerated aside from gastrointestinal side effects early on.
Spearmint tea is the most approachable option, though the evidence is modest. A randomized controlled trial in women with PCOS found that drinking spearmint tea twice daily for 30 days significantly reduced free and total testosterone levels.14PubMed. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial An earlier pilot study similarly found a decrease in free testosterone, leading the authors to suggest spearmint could be an alternative for mild hirsutism.15PubMed. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism The hormone changes were real, but neither study ran long enough to show whether they translate into visible hair reduction, which takes many months. Spearmint tea is not a replacement for prescription anti-androgens in moderate-to-severe cases, but for mild symptoms or as a supplement to other treatments, the data is encouraging.
Alternatives in Gender-Affirming Hormone Therapy
In feminizing hormone therapy for transgender women, spironolactone is one of the most commonly used anti-androgens in North America, paired with estradiol to suppress testosterone and promote feminization. It does bring testosterone down, though usually not all the way to typical female levels on its own, and it requires potassium monitoring.16PubMed Central. Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
Cyproterone acetate is the primary alternative used across Europe, Australia, and much of the rest of the world. It is a strong anti-androgen and progestin that reliably suppresses testosterone to female-range levels at relatively low doses. It is not available in the United States, which is part of why spironolactone dominates there. Cyproterone carries its own risks, including an association with elevated prolactin levels and, at higher doses, rare cases of liver problems and a small increased risk of meningioma.
GnRH agonists (drugs like leuprolide) offer highly effective testosterone suppression by shutting down the signal from the brain that tells the testes to produce testosterone. They are considered the most physiologically clean option in terms of side effects, but they require injections and are expensive, which limits access.
An increasingly discussed approach is estradiol monotherapy, meaning higher-dose estrogen without any anti-androgen at all. A study of transfeminine patients found that injectable estradiol monotherapy suppressed testosterone with no significant difference compared to estradiol combined with anti-androgens or progestogens.17PubMed. Injectable Estradiol Monotherapy Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy A smaller study found 100% testosterone suppression when estradiol levels exceeded a certain threshold, achieved through injectable or transdermal routes.18Journal of the Endocrine Society. 7472 Estrogen Monotherapy for Testosterone Suppression in Gender Diverse Patients Monotherapy simplifies regimens, eliminates the side effects of the anti-androgen entirely, and avoids potassium concerns. The open question is whether higher estrogen doses carry their own long-term cardiovascular or clotting risks, and the evidence on that is still maturing.
Staying on Spironolactone by Managing Its Side Effects
Sometimes the best substitute is not a different drug but a strategy that lets you keep taking spironolactone with fewer problems. Hyperkalemia is the side effect that most often forces discontinuation, particularly in people with kidney disease or those already on ACE inhibitors or angiotensin receptor blockers. Newer potassium binders, including patiromer and sodium zirconium cyclosilicate, can pull excess potassium out through the gut. These drugs have been studied specifically to enable patients to keep taking medications that raise potassium, including mineralocorticoid receptor antagonists.19PubMed Central. Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? The idea is straightforward: rather than losing the benefits of spironolactone, you add a drug that manages the potassium side effect. This approach is especially relevant in heart failure and kidney disease, where the evidence for aldosterone blockade is strongest and stopping it has real consequences.
For hormonal side effects like breast tenderness, dose reduction is often the first step. Many dermatologists find that doses as low as 25–50 mg work well for skin and hair conditions, whereas heart failure doses tend to be 25–50 mg as well but are harder to reduce without losing the survival benefit. Timing adjustments and splitting doses can also help with dizziness and lightheadedness.
What Happens When You Stop
If you are switching away from spironolactone rather than adding an alternative, the transition matters. Spironolactone has a long-acting metabolite, so its effects do not disappear overnight. A study of patients on spironolactone for high blood pressure found that after stopping the drug, body weight increased, blood volume rose, and blood pressure went back up in most patients.20PubMed. Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension The hormonal changes that kept renin and aldosterone elevated during treatment began reversing within weeks of stopping. For people using spironolactone for acne or hair loss, the return of androgen-driven symptoms is often gradual but noticeable over one to three months, which is why dermatologists usually start the replacement therapy before tapering spironolactone rather than leaving a gap.
The broader lesson is that there is no single “best” substitute for spironolactone. The right replacement depends on the condition being treated, the side effects you’re trying to escape, your other medications, your kidney function, and whether you’re looking for something prescription or more conservative. Discuss the switch with your prescriber so the transition can be planned around your specific situation rather than improvised.